Press releases
- Exelixis to Present at the William Blair 44th Annual Growth Stock Conference
- Exelixis Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Cipla Limited and Cipla USA
- Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May
- Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update
- Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024
More ▼
Key statistics
As of last trade Exelixis Inc (EX9:DUS) traded at 20.25, -8.20% below its 52-week high of 22.06, set on Apr 29, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 20.28 |
---|---|
High | 20.28 |
Low | 20.25 |
Bid | 20.18 |
Offer | 20.86 |
Previous close | 20.47 |
Average volume | 0.00 |
---|---|
Shares outstanding | 291.29m |
Free float | 284.89m |
P/E (TTM) | 34.26 |
Market cap | 6.45bn USD |
EPS (TTM) | 0.6466 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 11:31 BST.
More ▼